|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Anti-Certolizumab pegol (Cimzia®) ELISA | Alpha-Klotho (Soluble) ELISA Assay | Bordetella pertussis IgM ELISA | DPP4 / CD26 ELISA Assay | Influenza Virus A IgG ELISA |
| Citations | | | | | |
| Catalog Number | TM09035 | 27998 | IB79851 | 27789 | IB79878 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Enzyme immunoassay for the determination of free antibodies to Certolizumab pegol (CZP) in serum and plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human soluble a-Klotho in serum and EDTA-plasma. For research use only, not for use in diagnostic procedures. | The Bordetella pertussis IgM ELISA is intended for the determination of IgM class antibodies against Bordetella pertussis in human serum or plasma (citrate, heparin). For research use only - not for use in diagnostic procedures. | Solid phase sandwich enzyme-linked immunosorbent assay (ELISA) for the determination of DPP4 / CD26 in human serum, EDTA-plasma, urine, and CSF. For research use only, not for use in diagnostic procedures. | The Influenza Virus A IgG ELISA is intended for the qualitative determination of IgG class antibodies against Influenza Virus A in human serum or plasma (citrate, heparin). FDA exempt, can be used for in-vitro diagnostics. |
| Detection Target | sAPP Beta-w | Complement C4d | Serotonin | Human T-Cadherin(30K, 130K) | Sex Hormone Binding Globulin (SHBG) |
| Sample Type | Blood Plasma, CSF, Cell Culture Supernatant | Plasma | Multiple | Human serum and EDTA-plasma. | Human Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 0 / 30 - 1000 ng/mL | 93.75 to 6000 pg/mL | A cut-off control is used for the interpretation of results. | 125 to 8000 pg/mL | A cut-off control is used for the interpretation of results. |
| Sensitivity | 0.05 ng/mL | Inquire | 0.005 ng/mL x Correction Factor based upon volume of sample used. | 0.005 ng/mL | 0.1 nmol/L |
| Assay Time | 2 hour, 45 min. total incubation time. | 2 hrs (incubation) | 1 hr 45 mins (incubation) | 2 hrs (incubation) | 1 hr 45 mins (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |